| #1 | NHLBI | Immunoaffinity Lateral Flow Assay Device for Diagnosis of Sickle Cell Disease | Specific antibodies were developed for sickle hemoglobin |
| #2 | CDC | Rapid test for HCV core antigen (Phase I) | Specific antibodies for HCV core antigen were developed |
| #3 | CDC | Rapid test for HCV core antigen (Phase II) | Specific antibodies for HCV core antigen were developed |
| #4 | NIAID | Rapid Point of Care Detection for Serologic Status of Individuals for CMV and HSV Infection | Rapid test for CMV antibody detection was developed. This test is used by Fred Hutchinson Cancer Center in their Grail study for patient selection for the clinical trial |
| #5 | CDC | Immunoassay for Serological detection and quantification of Hepatitis B core antigen (Phase I) | Specific antibodies for HBV core antigen were developed (ELISA kit was developed) |
| #6 | CDC | Immunoassay for Serological detection and quantification of Hepatitis B core antigen (Phase II) | Specific antibodies for HBV core antigen were developed (ELISA kit was developed) |
| #7 | CDC | Developing Species-Specific Human Taeniasis Coproantigen Detection Immunoassays | Specific antibodies were developed for tapeworm |
| #8 | NCI | Point of Care Diagnostics for Liver Flukes Opisthorchis viverrini and Clonorchis sinensis | Specific antibodies were developed for liver flukes |
| #9 | NIAID | Affinity Reagents for the Immune System of Guinea Pigs (1st awards) | Specific antibodies were developed for 16 immune targets of guinea pig |
| #10 | NIAID | Affinity Reagents for the Immune System of Guinea Pigs (2nd awards) | Specific antibodies were developed for 16 immune targets of guinea pig |
| #11 | RADx | Point-of-Care Antigen Detection for SARS-COV-2 from Saliva | Specific antibodies for SARS-COV-2 NP were used to produce sensitive LFA rapid test for COVID-19 detection |
| #12 | NIAID | Point-of-Care HCV Core Antigen Detection (Phase I) | More specific antibodies for HCV core antigen were developed (LFA rapid tests are being developed) |
| #13 | NIAID | Point-of-Care HCV Core Antigen Detection (Phase II) | More specific antibodies for HCV core antigen were developed (LFA rapid tests are being developed) |
| #14 | NIAID | Affinity Reagents for the Immune System of Golden Hamster (1st awards) | Specific antibodies were developed for 14 immune targets of Hamster |
| #15 | NIAID | Affinity Reagents for the Immune System of Golden Hamster (2nd awards) | Specific antibodies were developed for 14 immune targets of Hamster |
| #16 | NIAID | Affinity Reagents for the Immune System of Swine | Specific antibodies were developed for 8 immune targets of swine |
| #17 | NCI | Rapid At-Home Detection for Serologic Status of HCV Infection | Rapid test for HCV antibody detection was developed |
| #18 | NIAID | IMPACT-TB Subcontract (NIAID) Affinity Reagents for the Immune System of Guinea Pigs | Scale-up production of antibodies developed for guinea pig in previous awards |
| #19 | NIAID | Point-of-Care HSV Serological Detection | Rapid test for HSV1 and HSV2 antibody detection was developed as multiplexed lateral flow assay |
| #20 | BARDA | RRPV-24-06-DxR2-008 | True Diagnostics Rapid Biothreat Diagnostics TrueDxTM Development And Manufacturing Platform (Qoolabs is the subcontractor to develop rabbit monoclonal antibodies for sensitive detection of Ebola and Marburg viruses) |
